Aclid is a biotechnology security and compliance automation platform.
Aclid has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in June 2023.
Aclid's investors include 2048 Ventures, IA Ventures.
Aclid is headquartered in New York, United States.
Aclid is a biotechnology security and compliance automation platform.
Aclid is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aclid — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/aclid. Accessed August 13, 2026.
VCBacked. (2023). Aclid — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/aclid
{{cite web |title=Aclid — Funding & Investors |url=https://www.vcbacked.co/company/aclid |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated